▲ SIGMATERMINAL Open Terminal →

Analyses / ORCL

ORCL Oracle Corp As of Jul 30, 2026
$117.74

Large-cap enterprise software. Strong margins, solid growth, high valuation. Today -1.85%; recent analyst upgrade noted.

Setup: Value with Growth Mix Confidence: 65 Horizon: 3–6 months Risk: Moderate Category: Large Cap / Enterprise Software
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals ORCL's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

EPS growth 24% YoY; 5Y revenue CAGR 10.7%; operating margin 30.6% (excellent); 25.4% net margin. Dividend yield 1.7%, payout ratio sustainable at 34%. Insider buys outnumber sells 54–83 over recent period. Forward P/E 20x reasonable for 10%+ growth profile. Cloud/AI tailwinds (Oracle Cloud, GenAI adoption) remain structural.

▼ Bear Case

P/E 20x, P/S 5.1x, EV/EBITDA 20.1x — all premium to historical and large-cap peers. Price-to-FCF 29x signals high expectations already priced in. Beta 1.75 (high volatility). Week52 high 346 vs. current 118 shows massive drawdown; no material news catalyst visible yet. Insider sells (83) still outnumber buys (54), net negative signal.

Valuation

FAIRLY PRICED with upside optionality — score 62/100

Forward P/E 20x is reasonable for a 24% EPS growth and 10% revenue growth profile. P/S 5.1x and EV/EBITDA 20x sit above historical mean but justified by margin quality (30.6% operating, 25.4% net). Price-to-FCF 29x is stretched, implying limited buffer. The 66% drawdown from 52-week high creates technical opportunity, but no intrinsic-value margin-of-safety yet apparent.

Technical Levels

Support · $116.20 (Today's intraday low; near-term floor) · $114.50 (52-week low; major support) · $110.00 (Round number & historical retracement target)

Resistance · $121.92 (Today's intraday high; immediate ceiling) · $130.00 (Breakout level; unlock further upside) · $150.00 (Medium-term target; recovery milestone)

RSI: Data unavailable

Financial Health

Score 68/100. Liquidity ratios (current 1.1, quick 1.0) adequate but not robust; suggests tight working capital or high short-term obligations. Debt, interest coverage, and long-term solvency data missing. Low tangible book value (5.65 vs. price 117.74) typical for intangible-heavy tech. Recommend checking SEC filings for full debt picture and FCF sustainability.

Catalysts

Q4 FY2024 Earnings (likely Feb–Mar 2025)8–12 weeksHighest relevance. Watch for Oracle Cloud revenue growth rate, margins, and forward guidance. Beat could reignite bull case; miss would validate bear thesis.
AI/GenAI Announcements (product launches, customer wins)Ongoing; next likely conference or earnings callMedium. Market hungry for evidence Oracle is capturing AI workloads. Concrete wins (e.g., major cloud customer migration to Oracle Cloud AI) could reset growth expectations.
Macro / Fed Rate OutlookContinuousMedium. Rising rates pressure growth-stock valuations; falling rates could re-rate ORCL higher. Beta 1.75 means ORCL moves 1.75x market swings.
Activist / M&A ActivityUnlikely near-term; speculativeLow-medium. ORCL size ($339B market cap) limits M&A optionality, but buyback or dividend hike could support stock.

Risk Flags

Valuation multiples elevated; limited margin of safety. Current price -66% off 52-week high — recovery assumption critical.
Beta 1.75 — expect 1.75x broader market volatility. Sector rotation and tech selloff can amplify downside.
Insider activity mixed: net positive on share count (buys >> sells in absolute), but recent transactions data unavailable — cannot confirm current insider appetite.
Provider data missing: ROE, ROA, ROIC, debt-to-equity, interest coverage, RSI, fundamentals/balance sheet detail. Limits precision on capital efficiency and financial health scoring.
Dividend yield 1.7% sustainable at 34% payout, but watch earnings beats/misses — any stumble could pressure payout or stock.

See ORCL's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock ORCL free →

Recent News

More Analyses

ORCL FAQ

Is ORCL a buy right now?

Oracle Corp's current read is a Value with Growth Mix setup with 65 confidence over a 3–6 months horizon. Valuation: FAIRLY PRICED with upside optionality. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is ORCL overvalued?

FAIRLY PRICED with upside optionality (valuation score 62/100). Forward P/E 20x is reasonable for a 24% EPS growth and 10% revenue growth profile. P/S 5.1x and EV/EBITDA 20x sit above historical mean but justified by margin quality (30.6% operating, 25.4% net). Price-to-FCF 29x is stretched, implying limited buffer. The 66% drawdown from 52-week high creates technical opportunity, but no intrinsic-value margin-of-safety yet apparent.

What are the risks of buying ORCL?

P/E 20x, P/S 5.1x, EV/EBITDA 20.1x — all premium to historical and large-cap peers. Price-to-FCF 29x signals high expectations already priced in. Beta 1.75 (high volatility). Week52 high 346 vs. current 118 shows massive drawdown; no material news catalyst visible yet. Insider sells (83) still outnumber buys (54), net negative signal.